Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Human Hypertension|February 20, 2022
Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetesKatie Harris, Paul Muntner, Mark Woodward, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2026
Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: Win ratio analysis of ADVANCE TrialSeverine Bompoint, Laurent Billot, Anushka Patel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2019
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical OutcomesToshiaki Ohkuma, Min Jun, John Chalmers, et al.
Hypertension (Dallas, Tex. : 1979)|December 11, 2013
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trialJohn Chalmers, Hisatomi Arima, Mark Woodward, et al.
Diabetes, Obesity & Metabolism|June 2, 2020
Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON studyToshiaki Ohkuma, Sanne A E Peters, Min Jun, et al.
Diabetes Care|December 11, 2024
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE TrialToshiaki Ohkuma, Katie Harris, Mark Woodward, et al.
Journal of Hypertension|September 9, 2024
Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trialNelson Wang, John Chalmers, Katie Harris, et al.
American Journal of Hypertension|June 16, 2026
Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trialSultana Shajahan, Mark Woodward, Craig S Anderson, et al.
Diabetes Care|March 21, 2020
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A<sub>1c</sub> in the ADVANCE TrialJingyan Tian, Toshiaki Ohkuma, Mark Cooper, et al.
Diabetes, Obesity & Metabolism|September 11, 2024
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE studyMiriam Pikkemaat, Mark Woodward, Peder Af Geijerstam, et al.
Pageof 8